Vol 13, No 5 (2017)
Case report
Published online: 2017-11-15
A patient with metastatic malignant melanoma treated with nivolumab: case report
DOI: 10.5603/OCP.2017.0027
Oncol Clin Pract 2017;13(5):230-232.
Abstract
This is a case report of a 41-year-old female patient diagnosed in 2012 with malignant melanoma of the right
cheek. She was treated surgically. In 2013 right-sided cervical lymphadenectomy was performed due to melanoma
metastases. Subsequently, new metastases were found in the lungs, liver, and bones. She was treated with
nivolumab. A partial remission of the disease was noted and response is currently ongoing.
Keywords: malignant melanomanivolumabimmunotherapy
References
- Charakterystyka produktu leczniczego. Niwolumab. EMA 2015.
- Robert C, Long GV, Brady B, et al. Nivolumab in previously untreated melanoma without BRAF mutation. N Engl J Med. 2015; 372(4): 320–330.
- Rutkowski P, Wysocki PJ, Nasierowska-Guttmejer A. Czerniaki skóry — zasady postępowania diagnostyczno- terapeutycznego w 2016 roku. Onkologia w Praktyce Klinicznej 2015.
- Postow MA, Chesney J, Pavlick AC, et al. Nivolumab and ipilimumab versus ipilimumab in untreated melanoma. N Engl J Med. 2015; 372(21): 2006–2017.